title: [Analysis of generic drug supply in France].
abstract: BACKGROUND
  The list of generic medicines (LGM), published since 1997 by the Agence Française de Sécurité Sanitaire des Produits de Santé (AFFSSaPS), the French Medicine Agency, concerns a special part of the medicines reimbursed by the National Health Insurance (Social Security). The objectives of the present study were: i) to describe the components of this list, based on pharmaceutical, economical and therapeutic characteristics, ii) to study differences between generic and reference products (formulations, excipients, prices, etc.), iii) to analyze information on excipients provided to health care professionals.
  
  
  METHODS
  The 21st version of the LGM (April 2001) was used. Therapeutic value was retrieved from the 2001 AFSSaPS report on the therapeutic value of 4490 reimbursed medicines. Information on excipients in the LGM and the Vidal dictionary (reference prescription book in France) was compared.
  
  
  RESULTS
  The products included in the LGM represent 20% of all reimbursed medicines. The mean price differences between generics and their reference products vary between 30 and 50% for more than two thirds of the generic groups. The therapeutic value of the products of the LGM was judged important in 71% of cases (vs 63% for the 4409 assessed medicines) and insufficient in 13% of cases (vs 19%). Information on excipients is often missing and sometimes erroneous.
  
  
  CONCLUSIONS
  Although the LGM is regularly revised and thus the generic market in perpetual change, the 2001 cross description of this pharmaceutical market provides much informations and raises some concern.
mesh_terms: D002626:Chemistry, Pharmaceutical; D016527:Drug Costs / Q000706:statistics & numerical data; D004345:Drug Industry; D016568:Drugs, Generic / Q000737:chemistry / Q000191:economics / Q000592:standards / Q000600:supply & distribution*; D005079:Excipients / Q000032:analysis; D005602:France; D006801:Humans; D040541:Marketing; D009313:National Health Programs / Q000191:economics; D017891:Pharmacoepidemiology; D010602:Pharmacopoeias as Topic; D012051:Reimbursement Mechanisms / Q000191:economics; D013810:Therapeutic Equivalency
chemical_list: D016568:Drugs, Generic; D005079:Excipients
vernacular_title: Analyse de l'offre de médicaments génériques.